Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 21.81
+0.07 (0.32%)
Oct 15, 2025, 2:45 PM CST
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 16.83 billion as of October 14, 2025. Its market cap has decreased by -11.88% in one year.
Market Cap
16.83B
Enterprise Value
16.04B
Revenue
2.32B
Ranking
n/a
PE Ratio
25.55
Stock Price
21.81
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 16.83B, an increase of 162.77%. That is a compound annual growth rate of 11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 16.83B | -25.90% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | 54.20B | 80.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 454.34B |
| WuXi AppTec | 309.48B |
| Shenzhen Mindray Bio-Medical Electronics | 292.67B |
| Sichuan Biokin Pharmaceutical | 148.35B |
| Shanghai United Imaging Healthcare | 128.25B |
| Zhangzhou Pientzehuang Pharmaceutical., | 118.25B |
| Aier Eye Hospital Group | 117.68B |
| Yunnan Baiyao Group Co.,Ltd | 102.29B |